RFQMR technology has a totally
different approach from conventional therapies such as chemotherapy,
radiotherapy or surgery.This safe treatment alternative may control the tumor growth process
through its effect in the cell division mechanism. It can stop tumor
activity and growth and provide relief to symptoms such as pain,
lack of appetite and weight loss.
The Cytotron is having significant impact in the treatment of
cancer and osteoarthritis in Asia & Europe, as evidenced by some
recently concluded clinical studies. In cancer, an all comer,
compassionate Phase I clinical trial was conducted in Bangalore,
India, to treat terminally ill cancer patients with metastatic
/end-stage disease, as well as degenerative diseases such as
osteoarthritis. RFQMR is a safe, affordable and effective
treatment alternative that uses very low frequency, non-ionizing,
non thermal electromagnetic waves in the radio or sub-radio
frequencies. In cancer, these waves are hypothetically believed to
trigger programmed cell death and stop tumor growth through its
effects on cell division. It is crucial to leverage the prevailing
state of the art genome-wide or pathway specific molecular
technologies (mutational analysis, gene expression profiling and
biomarker identification) to study the near and long term effects
and the mechanism of action of RFQMR in human tissues. This can be
enabled using in-vitro, in-vivo and ex-vivo systems of
tumor stem cells, multiple cell types, cell lines, tissue and
organ explants, human tumor xenografts, and other animal model
systems of disease. Parallel clinical studies need to be conducted
to expand the application of RFQMR to primary cancer and other
disease indications like pain management, macular degeneration,
tissue regeneration and wound healing, to name a few.. There is
on-going R&D for other indications such as multiple sclerosis,
macular degeneration, diabetic neuropathy & targeted drug
delivery, to name a few.
We can
make a change to this...
